series-a
Stage
2018
Founded
2
Investors
About
MultiplexDX develops next-generation molecular diagnostics for personalized cancer treatment. Technology can assess over 20,000 biomarkers simultaneously. EIC Accelerator recipient.
Explore MultiplexDx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.